ArticleClinical journal of gastroenterology2026
A case of encapsulating peritoneal sclerosis associated with tuberculous peritonitis.
Article in Clinical journal of gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a case of encapsulating peritoneal sclerosis (EPS) associated with tuberculous peritonitis. A man in his 50s presented with fever, anorexia, and abdominal distension and was urgently hospitalized because computed tomography (CT) revealed ascites. Despite hospitalization for 1 month, the diagnosis remained unclear and his condition worsened; therefore, the patient was transferred to our hospital. At our hospital, his fever reached approximately 38 °C and an upper abdominal mass was palpable. Contrast-enhanced CT revealed encapsulated ascites and extensive peritoneal thickening with adhesions, resulting in a diagnosis of EPS. Mycobacterium tuberculosis complex was detected in the ascitic fluid culture, thus confirming EPS secondary to tuberculous peritonitis. CT revealed rapid bowel dilatation, suggesting a high risk of ileus. We initiated treatment comprising four antituberculosis drugs (isoniazid, rifampicin, pyrazinamide, and ethambutol) and prednisolone (60 mg/day). The fever resolved rapidly and inflammatory markers improved. CT revealed resolution of ascites and bowel dilation. Therefore, the steroid dose was tapered. On day 28, the patient was discharged. This case highlights that tuberculosis should be considered as a cause of EPS in patients without a history of peritoneal dialysis, and that early steroid therapy is necessary to prevent EPS progression to ileus.
Indexed as
Identifiers
41251885What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.